Short-read Sequencing Market by Technology (Next-Generation Sequencing, Sanger Sequencing), Product (Consumables, Instruments, Services), Workflow, Application, End-User - Global Forecast 2024-2030

Short-read Sequencing Market by Technology (Next-Generation Sequencing, Sanger Sequencing), Product (Consumables, Instruments, Services), Workflow, Application, End-User - Global Forecast 2024-2030


The Short-read Sequencing Market size was estimated at USD 5.81 billion in 2023 and expected to reach USD 6.73 billion in 2024, at a CAGR 15.98% to reach USD 16.41 billion by 2030.

Global Short-read Sequencing Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Short-read Sequencing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Short-read Sequencing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Short-read Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., Almac Group, Azenta Life Sciences, BGI Genomics Co., Ltd., Eurofins Genomics LLC, F. Hoffmann La Roche AG, General Electric Company, Genexa AG, GenScript Biotech Corporation, Illumina, Inc., PerkinElmer, Inc., Qiagen N.V., Seven Bridges Genomics, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage



This research report categorizes the Short-read Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Technology
Next-Generation Sequencing
Sanger Sequencing
Product
Consumables
Instruments
Services
Workflow
Data Analysis
Pre-Sequencing
Sequencing
Application
Agrigenomics & Forensics
Clinical Investigation
Consumer Genomics
HLA Typing & Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Oncology
Reproductive Health
End-User
Academic Research
Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Short-read Sequencing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Short-read Sequencing Market?
3. What are the technology trends and regulatory frameworks in the Short-read Sequencing Market?
4. What is the market share of the leading vendors in the Short-read Sequencing Market?
5. Which modes and strategic moves are suitable for entering the Short-read Sequencing Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Short-read Sequencing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising demand for personalized medicine and companion diagnostics
5.1.1.2. Increasing demand attributed to low-cost sequencing in detection of unknown genetic variants in clinical research
5.1.1.3. Surge in demand from application areas such as oncology, infectious disease, reproductive screening and pharmacogenomics
5.1.2. Restraints
5.1.2.1. Shortage of skilled professionals and high cost
5.1.3. Opportunities
5.1.3.1. Ongoing developments to decrease the cost of genome sequencing
5.1.3.2. Growing collaboration for genetic sequencing
5.1.4. Challenges
5.1.4.1. Dearth of required infrastructure in emerging economies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Short-read Sequencing Market, by Technology
6.1. Introduction
6.2. Next-Generation Sequencing
6.3. Sanger Sequencing
7. Short-read Sequencing Market, by Product
7.1. Introduction
7.2. Consumables
7.3. Instruments
7.4. Services
8. Short-read Sequencing Market, by Workflow
8.1. Introduction
8.2. Data Analysis
8.3. Pre-Sequencing
8.4. Sequencing
9. Short-read Sequencing Market, by Application
9.1. Introduction
9.2. Agrigenomics & Forensics
9.3. Clinical Investigation
9.4. Consumer Genomics
9.5. HLA Typing & Immune System Monitoring
9.6. Metagenomics, Epidemiology & Drug Development
9.7. Oncology
9.8. Reproductive Health
10. Short-read Sequencing Market, by End-User
10.1. Introduction
10.2. Academic Research
10.3. Clinical Research
10.4. Hospitals & Clinics
10.5. Pharma & Biotech Entities
11. Americas Short-read Sequencing Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Short-read Sequencing Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Short-read Sequencing Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. 10x Genomics, Inc.
15.1.2. Agilent Technologies, Inc.
15.1.3. Almac Group
15.1.4. Azenta Life Sciences
15.1.5. BGI Genomics Co., Ltd.
15.1.6. Eurofins Genomics LLC
15.1.7. F. Hoffmann La Roche AG
15.1.8. General Electric Company
15.1.9. Genexa AG
15.1.10. GenScript Biotech Corporation
15.1.11. Illumina, Inc.
15.1.12. PerkinElmer, Inc.
15.1.13. Qiagen N.V.
15.1.14. Seven Bridges Genomics, Inc.
15.1.15. Thermo Fisher Scientific Inc.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
FIGURE 1. SHORT-READ SEQUENCING MARKET RESEARCH PROCESS
FIGURE 2. SHORT-READ SEQUENCING MARKET SIZE, 2023 VS 2030
FIGURE 3. SHORT-READ SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SHORT-READ SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. SHORT-READ SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SHORT-READ SEQUENCING MARKET DYNAMICS
FIGURE 7. SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 8. SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 10. SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
FIGURE 12. SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. SHORT-READ SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. SHORT-READ SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings